Digital Health

V-Patients

Non-Provider Industry Solutions

Accelerate clinical trials with digital patient twins, ensure their success, reduce costs and time

Virtonomy’s v-Patients software allows medical device developers to conduct development and testing within a virtual environment. The solution leverages a comprehensive digital twin and simulation platform built on a continually growing database of real clinical data, accurately representing anatomical differences, demographic diversity, and various pathological conditions.

Tech Brief
- Digital Patient Twins: Virtonomy offers a database of digital patient models created from real clinical data, including anatomical variability and pathological conditions.
  Virtual Environment: Users can simulate medical device implantation and performance in a virtual environment to optimize design and ensure safety.
  
  Key Features:
  Interactive Implantation: Perform virtual device fitting and measurements.
  Statistical Analysis: Access extensive statistics and worst-case anatomies.
  
  Regulatory Support: Generates digital evidence for regulatory compliance.

Differentiators
- Streamlined Development: Reduces development time and costs.
  
  Improved Safety: Enhances device safety through virtual testing.
  
  Regulatory Compliance: Supports compliance with FDA and European Commission standards.

Released
- 2022

Clinical Indication
Clinical Reference

End User
Clinicians, Researcher

Status
Released

Type
Software and Apps

Care Category
Clinical Trials

Functional Area
Research

FDA announcements
- Regulatory viewpoint:
  The FDA and European Commission show strong support for virtual patients and simulation.
  
  "FDA’s Office of Science and Engineering Laboratories (OSEL) has committed significant resources for transforming computational modeling from a valuable scientific tool to a valuable regulatory tool because of its potential for significant cost-savings in evaluating medical devices, simulating performance under scenarios that may not be possible with human use or that could more effectively be evaluated with simulation." (Source)
  
  More useful links:
  FDA’s support on computational modeling
  
  FDA: Diverse racial and ethnic groups for clinical trials

- --

Total Reviews: 0

No Review Available